RE:RE:New PR aroundVMOme very practical problem for the non-reaction on the trading volume may be that Bloomberg only put the headline of the press release out there and there is therefore no way for the trading algos that chase such announcements to read the actual press release.
It seems to me that there is some very important info in that article. But I will again defer to the science experts. One thing I noticed was that it appears that you need the combination of both the peptide and the Docetaxel/Doxorubicin in order to impede VM. I had been speculating that maybe the pepide alone clogging up the sortilin receptors was impeding VM and metastatis but the results suggest both aspects of the conjugate are needed.
stephanedodier wrote: I am a bit surprised that the volume is that low after this morning news...
Any comment ?